Mishchenko OY, Adonkina VY, Greshko II. The substantiation of the cost optimization for ER(+) HER2(−) breast cancer hormone therapy based on the results of the cost minimization pharmacoeconomic analysis. Soc. pharm. health care [Internet]. 2025May26 [cited 2025Jun.5];11(1):72-9. Available from: http://sphhcj.nuph.edu.ua/article/view/330647